National GLP-1 Outcomes Registry-in-a-Box

A ready-to-deploy registry that tracks long-term weight, cardiometabolic, safety, and equity outcomes for every patient started on GLP-1 therapy under new national guidelines — generating the long-term evidence WHO says is missing and that kept its recommendations conditional.